资讯
Regeneron's Dupixent leads growth as Eylea sales decline and valuation is attractive, but growth is delayed by 2-3 years.
Just discovered your data’s been breached? Learn the essential steps to protect your identity, crypto, and financial accounts fast.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果